FDA approves second Alzheimer’s drug that can slow onset of disease
The Pat Kenny Show · Newstalk
July 18, 202410m 43s
Audio is streamed directly from the publisher (bauernordic-pods.sharp-stream.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
The FDA in the US last Tuesday gave approval to an experimental new drug that has shown to delay the onset of Alzheimer’s disease in trials. Prof Luke O'Neill Professor of Biochemistry at the school of Immunology, Trinity College brought us the details.